Alpha-particle Monte Carlo simulation for microdosimetric calculations using a commercial spreadsheet

Physics in Medicine and Biology

Volumn 52, Issue 7, 2007, Pages 1909-1922

  Roeske, John C ^a   Hoggarth, Mark ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b DEPAUL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHMS; COMPUTER SIMULATION; ENERGY TRANSFER; INTERPOLATION; MONTE CARLO METHODS; PARTICLE BEAM DYNAMICS; SPREADSHEETS;

ALPHA-PARTICLE TRANSPORT; LINEAR ENERGY TRANSFER (LET); MICRODOSIMETRIC CALCULATIONS; MICRODOSIMETRIC SPECTRA;

ONCOLOGY;

ALGORITHM; ALPHA RADIATION; ARTICLE; CALCULATION; CELL NUCLEUS; COMPARATIVE STUDY; FIELD EMISSION; MICRODOSIMETRY; MONTE CARLO METHOD; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIATION ENERGY; SPECTRUM;

ALPHA PARTICLES; ANIMALS; CELL NUCLEUS; CYTOPLASM; DATA INTERPRETATION, STATISTICAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; LINEAR ENERGY TRANSFER; MODELS, STATISTICAL; MONTE CARLO METHOD; PROGRAMMING LANGUAGES; RADIOMETRY; RADIOTHERAPY DOSAGE; SOFTWARE; STOCHASTIC PROCESSES;

EID: 34247497372     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/52/7/010     Document Type: Article

References (31)

1. Allen B J, Raja C, Rizvi S, Li Y, Tsui W, Graham P, Thompson J F, Reisfeld R A and Kearsley J 2005 Intralesional targeted alpha therapy for metastatic melanoma Cancer Biol. Ther. 4 1318-24
2. Allen B J, Tian Z, Rizvi S M, Li Y and Ranson M 2003 Preclinical studies of targeted alpha therapy for breast cancer using 213Bi-labelled-plasminogen activator inhibitor type 2 Br. J. Cancer 88 944-50
3. Allen B J et al 2004 Targeted alpha therapy for cancer Phys. Med. Biol. 49 3703-12
4. Aubineau-Laniece I, Pihet P, Winkler R, Hofmann W and Charlton D E 2002 Monte Carlo code for microdosimetry of inhaled alpha emitters Radiat. Prot. Dosim. 99 463-8
5. Beyer G J, Miederer M, Vranjes-Duric S, Comor J J, Kunzi G, Hartley O, Senekowitsch-Schmidtke R, Soloviev D and Buchegger F 2004 Targeted alpha therapy in vivo: direct evidence for single cancer cell kill using 149Tb-rituximab Eur. J. Nucl. Med. Mol. Imaging 31 547-54
6. Charlton D E 1999 The survival of monolayers of cells growing in clusters irradiated by 211At appended to the cell surfaces Radiat. Res. 151 750-3
7. Charlton D E 2000 Radiation effects in spheroids of cells exposed to alpha emitters Int. J. Radiat. Biol. 76 1555-64
8. Charlton D E and Sephton R 1991 A relationship between microdosimetric spectra and cell survival for high-LET irradiation Int. J. Radiat. Biol. 59 447-57
9. Couturier O, Supiot S, Degraef-Mougin M, Faivre-Chauvet A, Carlier T, Chatal J F, Davodeau F and Cherel M 2005 Cancer radioimmunotherapy with alpha-emitting nuclides Eur. J. Nucl. Med. Mol. Imaging 32 601-14
10. Eckerman K F, Ryman J C, Taner A C and Kerr G D 1985 Traversal of cells by radiation and absorbed dose fractions for electrons and alpha particles Proc. 4th Int. Radiopharmaceutical Dosimetry Symp. ed A T Schlafke-Stetson and E E Watson (Oak Ridge, TN: Oak Ridge Associated Universities) pp 67-86 (CONF-851113)
11. Hall E J 1978 Radiobiology for the Radiologist 5th edn (Hagerstown MD: Harper and Row) pp 112-23
12. Huber R et al 2003 Locoregional alpha-radioimmunotherapy of intraperitoneal tumor cell dissemination using a tumor-specific monoclonal antibody Clin. Cancer Res. 9 3922S-8S
13. Humm J L 1987 A microdosimetric model of astatine-211 labeled antibodies for radioimmunotherapy Int. J. Radiat. Oncol. Biol. Phys. 13 1767-73
14. Humm J L, Roeske J C, Fisher D R and Chen G T Y 1993 Microdosimetric concepts in radioimmunotherapy Med. Phys. 20 535-42
15. ICRU 1993 Stopping powers and ranges for protons and alpha particles Report No 49 (Bethesda MD: International Commission of Radiation Units)
16. Jurcic J G et al 2002 Targeted α particle immunotherapy for myeloid leukemia Blood 100 1233-9
17. Li Y, Russell P J and Allen B J 2004 Targeted alpha-therapy for control of micrometastatic prostate cancer Expert Rev. Anticancer Ther. 4 459-68
18. Li Y, Tian Z, Rizvi S M, Bander N H and Allen B J 2002 In vitro and preclinical targeted alpha therapy of human prostate cancer with Bi-213 labeled J591 antibody against the prostate specific membrane antigen Prost. Cancer Prostatic Dis. 5 36-46
19. Microsoft 2006 Description of the RAND Function in Excel 2003 and in Excel 2007, Article 828795 http://support.microsoft.com/default.aspx?scid=kb;en- us;828795&Product=OFF2003
20. Nilsson S, Larsen R H, Fossa S D, Balteskard L, Borch K W, Westlin J E, Salberg G and Bruland O S 2005 First clinical experience with alpha-emitting radium-223 in the treatment of skeletal metastases Clin. Cancer Res. 11 4451-9
21. Palm S, Back T, Claesson I, Delle U, Hultborn R, Lindegren S and Jacobsson L 2003 Single-cell irradiation from [211At] astatine-labeled C215 monoclonal antibody: improved estimates of radiosensitivity from measurements on cellular uptake and retention Anticancer Res. 23 1219-21
22. Polig E 1978 Localized alpha-dosimetry Current Topics in Radiation Research vol 13 ed M Ebert and A Howard (Amsterdam: North-Holland) pp 189-327
23. Roeske J C and Stinchcomb T G 1999 The use of microdosimetric moments in evaluating cell survival for therapeutic alpha-particle emitters Radiat. Res. 151 31-8
24. Seidl C et al 2004 Cell death triggered by alpha-emitting 213Bi-immunoconjugates in HSC45-M2 gastric cancer cells is different from apoptotic cell death Eur. J. Nucl. Med. Mol. Imaging 32 274-85
25. Sofou S, Thomas J L, Lin H Y, McDevitt M R, Scheinberg D A and Sgouros G 2004 Engineered liposomes for potential alpha-particle therapy of metastatic cancer J. Nucl. Med. 45 253-60
26. Stinchcomb T G and Roeske J C 1992 Analytic microdosimetry for radioimmunotherapeutic alpha-particle emitters Med. Phys. 19 1385-93
27. Stinchcomb T G and Roeske J C 1994 Analysis of survival of C-18 cells after irradiation in suspension with chelated and ionic bismuth-212 using microdosimetry Radiat. Res. 140 48-54
28. 1〉 for dosimetry using alpha particle emitters Med. Phys. 26 1960-71
29. Utteridge T D, Charlton D E and Allen B J 2001 Monte Carlo modeling of the effects of injected short-, medium- and longer-range alpha particle emitters on human marrow at various ages Radiat. Res. 156 413-8
30. Zalutsky M R 2005 Current status of therapy of solid tumors: Brain tumor study J. Nucl. Med. 46 (Suppl. 1) 151S-6S
31. Zalutsky M R 2006 Targeting α-particle therapy of microscopic disease: providing a further rationale for clinical investigation J. Nucl. Med. 47 1238-40